Stem Cell Research Oversight: Policies and Guidance

Note: Effective January 22, 2026, NIH funds will no longer be used to support research involving human fetal tissue from elective abortions.

Overall Policy:

• UW–Madison Policy for Human Embryo and Human Pluripotent Stem Cell Research​

Protocol Guidance:

• PI Status for UW–Madison hESC Protocols and Form to Request to Serve as  PI.
• UW–Madison SCRO Initial Review, Continuing Review, and Changes of Protocol Policy
• UW–Madison SCRO Full and Expedited Review Policy​
• UW–Madison SCRO Multisite Research Policy​

• SCRO Protocol Processes Guidance
• UW–Madison SCRO Chimera Guidance
• UW–Madison SCRO Guidance for Documentation of Provenance
• UW–Madison Guidance for Investigators Requesting to Add hESC Lines to the UW–Madison hESC Registry​
• Guidance for the use of de-identified fetal material in research

• ISSCR 2021 Guidelines for Stem Cell Research and Clinical Translation
• Hyun 2021 ISSCR chimeras
• Considerations leading to the revised ISSCR guidelines 2021
• Why stem cell guidelines needed an update, Lovell-Badge Nature 2021